Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-25

Clinical Trial Update: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines [Phase 1]

View source ↗

Summary

Phase 1 study of novel oral poliomyelitis vaccines for serotypes 1 and 3. The trial has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Type 1 Oral Poliomyelitis Vaccine (Oral Poliovirus Vaccine Type 1)
  • Novel Type 3 Oral Poliomyelitis Vaccine (Oral Poliovirus Vaccine Type 3)

Snippet

Sponsor: PATH | Conditions: Poliomyelitis | Phase 1 | Status: COMPLETED | Results posted: 2024-09-25